53
41) Diamandidou E, Colome M, Fayad L, Duvic M, Kurzrock R. Prognostic factor analysis in mycosis fungoides/Szary syndrome. J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):91424.
42) Trautinger F, Knobler R, Willemze R, Peris K, Stadler R, Laroche L. EORTC consensus recommendations for the treatment of mycosis fungoides/Szary syndrome. Eur J Cancer 2006; 42: 1014-30.
43) Knobler E. Current management strategies for cutaneous T-cell lymphoma. Clin Dermatol 2004; 22: 197-208.
44) Gilchrest BA, Parrish JA, Tanenbaum L, Haynes HA, Fitzpatrick TB. Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 1976; 38: 683-9.
45) Whittaker SJ, Marsden JR, Spittle M, Russell Jones R; British Association of Dermatologists; U.K. Cutaneous Lymphoma Group. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 2003; 149: 1095-1107.
46) Herrmann JJ, Roenigk HH Jr, Hurria A, Kuzel TM, Samuelson E, Rademaker AW, Rosen ST. Treatment of mycosis fungoides with photochemotherapy (PUVA): longterm follow-up. J Am Acad Dermatol 1995; 33: 234-42.
47) Querfeld C, Rosen ST, Kuzel TM, Kirby KA, Roenigk HH Jr, Prinz BM, Guitart J. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy. Arch Dermatol 2005; 141: 305-11.
48) Roupe G, Sandström MH, Kjellström C. PUVA in early mycosis fungoides may give long-term remission and delay extracutaneous spread. Acta Derm Venereol 1996; 76: 475-8.
49) Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-71.
50) Hofer A, Cerroni L, Kerl H, Wolf P. Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol 1999; 135: 1377-80.
51) Pavlotsky F, Barzilai A, Kasem R, Shpiro D, Trau H. UVB in the management of early stage mycosis fungoides. J Eur Acad Dermatol Venereol 2006; 20: 565-72.
52) Boztepe G, Sahin S, Ayhan M, Erkin G, Kilemen F. Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides. J Am Acad Dermatol 2005; 53: 242-6.



62. SAYFAYA BENZER SAYFALAR

Son on yılda kliniğimizde takip edilen Mycozis Fungoides vakalarının retrospektif değerlendirilmesi - Sayfa 80
91. Kaymaz R. Mikozis Fungoidesli hastalarda HLA-DRB1* ve HLA-DQB1* alellerinin sıklıgının arastırılması. Uzmanlık Tezi, İstanbul Üniversitesi İstanbul Tıp Fakültesi Dermatoloji Anabilim Dalı, İstanbul. 2003 92. Tan ES, Tang MB, Tan SH. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore, Australas.J Dermatol. 2006 Nov...
Mikozis fungoides yama evresi olan hastalarda dar-band UVB ve dar-band UVB+izotretinoin tedavilerinin apopitoz üzerine etkisi ve bunun klinik yanıtla karşılaştırılması - Sayfa 76
47. Olsen E, Vonderheid E, Pimpinelli N et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007:15;1713-22. 48. Prince HM, Whittaker S, Hoppe RT. How I treat mycosis f...
Kutanöz T hücreli lenfoma hastalarında periferal kan CD4+ T lenfositlerde CD26 ekspresyonunun akım sitometrik yöntemle araştırılması - Sayfa 83
133-Smoller BR, Detwiler SP, Kohler S, Hoppe RT, Kim YH. Role of histology in providing prognostic information in mycosis fungoides. J Cutan Pathol 1998;25:311-315. 134-Gerami P, Rosen S, Kuzel T, Boone SL, Guitart J. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma. Arch Dermatol 2008;144:738-746. 135-Kim EJ, Hess S, Richardson SK. Immunopathogenesis and the...

62. SAYFADAKI ANAHTAR KELIMELER

mycosis
stage
dermatol
fungoides
derm
treatment


62. SAYFA ICERIGI

53
41) Diamandidou E, Colome M, Fayad L, Duvic M, Kurzrock R. Prognostic factor analysis in mycosis fungoides/Szary syndrome. J Am Acad Dermatol. 1999 Jun;40(6 Pt 1):91424.
42) Trautinger F, Knobler R, Willemze R, Peris K, Stadler R, Laroche L. EORTC consensus recommendations for the treatment of mycosis fungoides/Szary syndrome. Eur J Cancer 2006; 42: 1014-30.
43) Knobler E. Current management strategies for cutaneous T-cell lymphoma. Clin Dermatol 2004; 22: 197-208.
44) Gilchrest BA, Parrish JA, Tanenbaum L, Haynes HA, Fitzpatrick TB. Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 1976; 38: 683-9.
45) Whittaker SJ, Marsden JR, Spittle M, Russell Jones R; British Association of Dermatologists; U.K. Cutaneous Lymphoma Group. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 2003; 149: 1095-1107.
46) Herrmann JJ, Roenigk HH Jr, Hurria A, Kuzel TM, Samuelson E, Rademaker AW, Rosen ST. Treatment of mycosis fungoides with photochemotherapy (PUVA): longterm follow-up. J Am Acad Dermatol 1995; 33: 234-42.
47) Querfeld C, Rosen ST, Kuzel TM, Kirby KA, Roenigk HH Jr, Prinz BM, Guitart J. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy. Arch Dermatol 2005; 141: 305-11.
48) Roupe G, Sandström MH, Kjellström C. PUVA in early mycosis fungoides may give long-term remission and delay extracutaneous spread. Acta Derm Venereol 1996; 76: 475-8.
49) Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-71.
50) Hofer A, Cerroni L, Kerl H, Wolf P. Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol 1999; 135: 1377-80.
51) Pavlotsky F, Barzilai A, Kasem R, Shpiro D, Trau H. UVB in the management of early stage mycosis fungoides. J Eur Acad Dermatol Venereol 2006; 20: 565-72.
52) Boztepe G, Sahin S, Ayhan M, Erkin G, Kilemen F. Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides. J Am Acad Dermatol 2005; 53: 242-6.

İlgili Kaynaklar

single.php